Navigation Links
Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean
Date:11/27/2007

WILMINGTON, N.C., Nov. 27 /PRNewswire-FirstCall/ -- PPD, Inc. (Nasdaq: PPDI) today announced the appointment of Jose Luis Viramontes, M.D., as associate director of clinical operations, to lead the company's delivery of drug development services in Mexico, Central America and the Caribbean. Based in Mexico City, Dr. Viramontes will provide overall management of PPD clinical services in the region.

"Dr. Viramontes brings a solid understanding of the pharmaceutical industry in Mexico, extensive clinical research experience and strong leadership skills," said Wendy Buckland, senior executive director of clinical operations for Latin America. "He will play a lead role in expanding our global presence in Latin America, and we are pleased to welcome him to PPD."

A physician, Dr. Viramontes joins PPD from Merck Sharp & Dohme Mexico where he spent 14 years in roles with increasing responsibilities. Most recently, he served as clinical research associate director. In this role, he oversaw clinical trials, including site validation and selection; identified and developed clinical research preferred partners; ensured consistency of process and protocol implementation; and coordinated clinical research training. His earlier roles with Merck included market expansion manager, medical director, product manager and cardiovascular medical manager.

Dr. Viramontes earned a medical degree from the Universidad Nacional Autonoma de Mexico and completed a specialty in respiratory medicine at the General Hospital of Mexico. He also holds a master in sciences certificate in medical sciences and clinical research. He earned a certificate in clinical epidemiology and health economics from McMaster University in Ontario, Canada. In addition, Dr. Viramontes has a post-graduate certificate in marketing and is knowledgeable of Six Sigma methodology.

PPD is a leading global contract research organization providing discovery, development and post-approval service
'/>"/>

SOURCE PPD, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
6. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
9. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
10. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 GenomeDx Biosciences today ... Prostate Cancer Classifier, a genomic test for prostate cancer, ... high-risk men managed by radical prostatectomy without adjuvant therapy. ... is relatively uncommon, using tumor genomics to identify these ... disease is an important advance. The study has been ...
(Date:12/22/2014)... December 22, 2014 The ... publication of original research, reviews and editorials addressing ... clinical practice, today published a provocative article exploring ... development, progression and potential treatment of prostate cancer. ... research and proposes the possibility that there could ...
(Date:12/22/2014)... TENN (PRWEB) December 22, 2014 Fertility ... Donor Egg Bank USA , a network of ... country. Through this partnership, patients have fast access to ... in vitro fertilization, IVF . Fertility Associates of Memphis ... offer this fertility treatment option. , Dr. William ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Charm Sciences ... test for the Detection of Aflatoxin M1 in raw ... receive independent third party validation. The peer reviewed report ... of the Institute for Agricultural and Fisheries Research (ILVO-T&V) ... , Aflatoxin B1, the most toxic aflatoxin and ...
Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... University and United States Army scientists have found that ... can be made to produce brilliant light best suited ... Henry Everitt, chemistry professor Jie Liu and their graduate ... ultra-fine powders of commonplace zinc oxide at about 1,000 ...
... test their knowledge at www.synbioproject.org , ... Esquire magazine recently chose as the most influential in ... combines science and engineering in order to design and build novel ... , , The promise of this ...
... Once thought of as,a technology used only for ... CUDA(TM) technology are now being used for the,serious ... Network Computing (BOINC), one of the leading distributed ... to tap the massively parallel,processing power of NVIDIA ...
Cached Biology Technology:Duke researchers coax bright white light from unexpected source 2Duke researchers coax bright white light from unexpected source 3Synthetic Biology Importance in the 21st Century 2Synthetic Biology Importance in the 21st Century 3NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 2NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 3NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 4NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 5NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 6
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/5/2014)... 4, 2014 Increased emphasis on product ... new testing and inspection technologies. The convergence of ... a range of innovative test solutions. This trend ... Y, which is generally more inclined towards communication, ... development strategies of test equipment vendors will cater ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... collaboration with the University of California at San Diego (UCSD) ... some aspects of gastropod (snails and slugs) locomotion to basically ... depend on the physical properties of their mucus to propel ... mechanism to the construction of biomimetic robots. "The aim ...
... to be only a structural support protein in the microenvironment ... cross-like shape. However, laminin is far more than ... led by one of the world,s foremost breast cancer scientists ... development of breast cancer, ,the second most common cancer and ...
... and the German Cancer Research Centre (DKFZ), both in ... the combined effects of genes. Published online today in ... genes can amplify, cancel out or mask each others, ... with each other in much the same manner that ...
Cached Biology News:A study reveals the keys to the locomotion of snails 2A study reveals the keys to the locomotion of snails 3Berkeley Lab researchers illuminate laminin's role in cancer formation 2Berkeley Lab researchers illuminate laminin's role in cancer formation 3Berkeley Lab researchers illuminate laminin's role in cancer formation 4Berkeley Lab researchers illuminate laminin's role in cancer formation 5Suggesting genes' friends, Facebook-style 2
SCP-1 (P-17)...
Rabbit polyclonal to Kallikrein 1 ( Abpromise for all tested applications). Antigen: Full length native kallikrein from tissue (Human) Entrez Gene ID: 3816 Swiss Protein ID: P06870...
PSGL-1 (215)...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
Biology Products: